SCHEMBL18018359

SCHEMBL18018359

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5nc(-c6ccc(-c7ccccc7)cc6)c6c(n5)oc5ccccc56)cc4)c4c(n3)oc3ccccc34)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ ATM Q13315 1/20 0.44
▸ MAPT P10636 6/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ HTT P42858 2/20 0.40
▸ CSF1R P07333 1/20 0.40
▸ PDGFRB P09619 1/20 0.40
▸ KIT P10721 1/20 0.40
▸ FLT3 P36888 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ WHR1 P49842 1/20 0.38
▸ LMNA P02545 3/20 0.37
▸ ALDH1A1 P00352 5/20 0.37
▸ TSHR P16473 2/20 0.37
▸ POLB P06746 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18370601 1.00 KMT2A (0.44) KMT2AMEN1ATMMAPTSMN1; SMN2
SCHEMBL16902564 1.00 KMT2A (0.44) KMT2AMEN1ATMMAPTSMN1; SMN2
SCHEMBL18017780 1.00 KMT2A (0.44) KMT2AMEN1ATMMAPTSMN1; SMN2
SCHEMBL16902590 1.00 KMT2A (0.44) KMT2AMEN1ATMMAPTSMN1; SMN2
SCHEMBL18017797 1.00 KMT2A (0.44) KMT2AMEN1ATMMAPTSMN1; SMN2
SCHEMBL18017795 1.00 KMT2A (0.44) KMT2AMEN1ATMMAPTSMN1; SMN2
SCHEMBL18017935 1.00 KMT2A (0.44) KMT2AMEN1ATMMAPTSMN1; SMN2
SCHEMBL18370598 1.00 KMT2A (0.44) KMT2AMEN1ATMMAPTSMN1; SMN2
SCHEMBL18017880 1.00 KMT2A (0.44) KMT2AMEN1ATMMAPTSMN1; SMN2
SCHEMBL18018392 1.00 KMT2A (0.44) KMT2AMEN1ATMMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160240791-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2016-08-18 — — US disclosed
US-20160240791-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2016-08-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160240791-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OR10J3, OXER1, OCIAD1 KMT2A 4272/4885MEN1 3118/4885ATM 4280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback